Dysregulation of the human FASTK family is associated with autoimmune diseases and genetic mitochondrial disorders, often resulting in altered energy production along with a broad range of clinical presentations, including severe impairment to neurological, muscular, and kidney function [13–19]. This evidence concerns the gene FASTK and autoimmune disease.